{"id":"saline-09","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperchloremic acidosis (with prolonged or excessive use)"},{"rate":null,"effect":"Fluid overload / pulmonary edema (in susceptible patients)"},{"rate":null,"effect":"Hypernatremia (rare, with excessive administration)"}]},"_chembl":{"chemblId":"CHEMBL2108783","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Normal saline (0.9% NaCl) matches the osmolarity of blood plasma, allowing it to be administered intravenously or topically without causing cell lysis or crenation. It serves as a physiologic replacement fluid for lost body fluids, maintains intravascular volume, and preserves electrolyte balance. It is a fundamental supportive therapy rather than a drug with a specific pharmacologic mechanism.","oneSentence":"Saline 0.9% is an isotonic sodium chloride solution that restores fluid balance and electrolyte homeostasis in the body.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:37:26.432Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Fluid and electrolyte replacement in dehydration"},{"name":"Maintenance of intravascular volume during surgery or critical illness"},{"name":"Vehicle for intravenous drug administration"},{"name":"Wound irrigation and topical cleansing"}]},"trialDetails":[{"nctId":"NCT05289037","phase":"PHASE2","title":"COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-03-30","conditions":"COVID-19","enrollment":1270},{"nctId":"NCT06121141","phase":"PHASE4","title":"Comparison of Two Different Concentrations of Local Anesthetic in Patient Reported Pain in Oculoplastic Surgery","status":"COMPLETED","sponsor":"Timothy Ekhlassi","startDate":"2023-08-07","conditions":"Dermatochalasis, Dermatochalasis of Eyelid, Dermatochalasis of Both Upper Eyelids","enrollment":30},{"nctId":"NCT05582798","phase":"PHASE4","title":"Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2022-11-01","conditions":"Bronchiectasis Adult","enrollment":20},{"nctId":"NCT03901612","phase":"PHASE4","title":"Erector Spinae Catheter for Open Heart Surgery","status":"WITHDRAWN","sponsor":"Vinmec Healthcare System","startDate":"2019-01-05","conditions":"Post Operative Analgesia","enrollment":""},{"nctId":"NCT04586751","phase":"NA","title":"The Impact of Pecs Blocks on Postmastectomy Pain Syndrome","status":"COMPLETED","sponsor":"Aretaieion University Hospital","startDate":"2020-08-01","conditions":"Pain Syndrome, Pain, Postoperative, Chronic Pain","enrollment":64},{"nctId":"NCT04397718","phase":"PHASE2","title":"Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2020-07-06","conditions":"COVID-19","enrollment":96},{"nctId":"NCT03207152","phase":"PHASE1","title":"Biomarkers Predicting Infectivity in an Experimental Human Influenza Model","status":"UNKNOWN","sponsor":"Duke University","startDate":"2017-09-11","conditions":"Influenza A","enrollment":50},{"nctId":"NCT00969878","phase":"PHASE2","title":"Multisite Controlled Trial of Cocaine Vaccine","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2010-08","conditions":"Cocaine Dependence","enrollment":300},{"nctId":"NCT01050114","phase":"PHASE3","title":"OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER","status":"UNKNOWN","sponsor":"Christopher Patrick Smith","startDate":"2013-08","conditions":"Overactive Bladder","enrollment":36},{"nctId":"NCT01177202","phase":"PHASE1","title":"Study of the Safety and Immunogenicity of H1N1 Vaccine","status":"COMPLETED","sponsor":"Fraunhofer, Center for Molecular Biotechnology","startDate":"2010-09","conditions":"H1N1 Flu","enrollment":80},{"nctId":"NCT00994110","phase":"PHASE3","title":"Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2009-10","conditions":"Pancreatic Cancer","enrollment":439},{"nctId":"NCT00974818","phase":"PHASE3","title":"Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients","status":"TERMINATED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2009-09","conditions":"Bladder Cancer","enrollment":50},{"nctId":"NCT01520441","phase":"EARLY_PHASE1","title":"BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)","status":"WITHDRAWN","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2011-03","conditions":"Prostate Cancer, Benign Prostatic Hyperplasia, Enlarged Prostate With Lower Urinary Tract Symptoms (LUTS)","enrollment":""},{"nctId":"NCT01528722","phase":"NA","title":"Randomized Control Trial of Intraperitoneal Bupivacaine During Cholecystectomy","status":"COMPLETED","sponsor":"University Hospitals Coventry and Warwickshire NHS Trust","startDate":"2009-01","conditions":"Cholecystitis, Gall Stone Pancreatitis","enrollment":42},{"nctId":"NCT01248325","phase":"PHASE3","title":"A Study of Luffa Operculate Nasal Solution 5mg/mL Compared With Saline (NaCl 09%) for the Relief of Nasal Obstruction","status":"UNKNOWN","sponsor":"Zurita Laboratorio Farmaceutico Ltda.","startDate":"2011-01","conditions":"Rhinitis, Sinusitis","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2606,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"saline 09%","genericName":"saline 09%","companyName":"Vinmec Healthcare System","companyId":"vinmec-healthcare-system","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Saline 0.9% is an isotonic sodium chloride solution that restores fluid balance and electrolyte homeostasis in the body. Used for Fluid and electrolyte replacement in dehydration, Maintenance of intravascular volume during surgery or critical illness, Vehicle for intravenous drug administration.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}